AbstractShK, a 35-residue peptide from a sea anemone, is a potent blocker of potassium channels. Here we describe a new ShK analogue with an additional C-terminus Lys residue and amide. ShK-K-amide is a potent blocker of Kv1.3 and, in contrast to ShK and ShK-amide, is selective for Kv1.3. To understand this selectivity, we created complexes of ShK-K-amide with Kv1.3 and Kv1.1 using docking and molecular dynamics simulations, then performed umbrella sampling simulations to construct the potential of mean force of the ligand and calculate the corresponding binding free energy for the most stable configuration. The results agree well with experimental data
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
ShK, a 35-residue peptide from a sea anemone, is a potent blocker of potassium channels. Here we des...
AbstractShK, a 35-residue peptide from a sea anemone, is a potent blocker of potassium channels. Her...
The voltage-gated potassium channel Kv1.3 is an attractive target for treatment of autoimmune diseas...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is an established target for treatment of autoimmune disea...
ABSTRACT: Peptide toxins that adopt the ShK fold can inhibit the voltage-gated potassium channel KV1...
The voltage-gated potassium channel Kv1.3 is an important target for the treatment of autoimmune dis...
The voltage-gated potassium channel Kv1.3 is an important target for the treatment of autoimmune dis...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
ShK, a 35-residue peptide from a sea anemone, is a potent blocker of potassium channels. Here we des...
AbstractShK, a 35-residue peptide from a sea anemone, is a potent blocker of potassium channels. Her...
The voltage-gated potassium channel Kv1.3 is an attractive target for treatment of autoimmune diseas...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is a well-established target for treatment of autoimmune d...
The voltage-gated potassium channel Kv1.3 is an established target for treatment of autoimmune disea...
ABSTRACT: Peptide toxins that adopt the ShK fold can inhibit the voltage-gated potassium channel KV1...
The voltage-gated potassium channel Kv1.3 is an important target for the treatment of autoimmune dis...
The voltage-gated potassium channel Kv1.3 is an important target for the treatment of autoimmune dis...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...
BgK is a peptide from the sea anemone Bunodosoma granulifera, which blocks Kv1.1, Kv1.2, and Kv1.3 p...